A detailed history of Eagle Rock Investment Company, LLC transactions in Johnson & Johnson stock. As of the latest transaction made, Eagle Rock Investment Company, LLC holds 40,781 shares of JNJ stock, worth $6.3 Million. This represents 1.13% of its overall portfolio holdings.

Number of Shares
40,781
Previous 42,173 3.3%
Holding current value
$6.3 Million
Previous $6.16 Million 7.2%
% of portfolio
1.13%
Previous 1.13%

Shares

12 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Oct 07, 2024

SELL
$145.48 - $167.38 $202,508 - $232,992
-1,392 Reduced 3.3%
40,781 $6.61 Million
Q2 2024

Jul 12, 2024

BUY
$144.38 - $157.78 $8,807 - $9,624
61 Added 0.14%
42,173 $6.16 Million
Q1 2024

Apr 15, 2024

SELL
$155.22 - $162.74 $2.15 Million - $2.26 Million
-13,858 Reduced 24.76%
42,112 $6.66 Million
Q4 2023

Jan 12, 2024

SELL
$145.6 - $158.88 $707,179 - $771,680
-4,857 Reduced 7.98%
55,970 $8.77 Million
Q3 2023

Oct 10, 2023

SELL
$155.75 - $174.48 $203,409 - $227,870
-1,306 Reduced 2.1%
60,827 $9.47 Million
Q2 2023

Jul 19, 2023

SELL
$154.35 - $166.11 $104,031 - $111,958
-674 Reduced 1.07%
62,133 $10.3 Million
Q1 2023

Apr 10, 2023

SELL
$151.05 - $180.26 $286,692 - $342,133
-1,898 Reduced 2.93%
62,807 $9.74 Million
Q4 2022

Jan 25, 2023

SELL
$160.2 - $179.79 $300,214 - $336,926
-1,874 Reduced 2.81%
64,705 $0
Q3 2022

Nov 08, 2022

SELL
$161.33 - $179.52 $1.38 Million - $1.54 Million
-8,563 Reduced 11.4%
66,579 $10.9 Million
Q2 2022

Aug 12, 2022

SELL
$168.19 - $186.01 $492,460 - $544,637
-2,928 Reduced 3.75%
75,142 $13.3 Million
Q1 2022

May 11, 2022

SELL
$158.14 - $179.59 $1.08 Million - $1.23 Million
-6,852 Reduced 8.07%
78,070 $13.8 Million
Q4 2021

Feb 17, 2022

BUY
$155.93 - $173.01 $13.2 Million - $14.7 Million
84,922 New
84,922 $14.5 Million

Others Institutions Holding JNJ

About JOHNSON & JOHNSON


  • Ticker JNJ
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 2,614,479,872
  • Market Cap $404B
  • Description
  • Johnson & Johnson, together with its subsidiaries, researches and develops, manufactures, and sells various products in the healthcare field worldwide. The company's Consumer Health segment offers baby care products under the JOHNSON'S and AVEENO Baby brands; oral care products under the LISTERINE brand; skin health/beauty products under the...
More about JNJ
Track This Portfolio

Track Eagle Rock Investment Company, LLC Portfolio

Follow Eagle Rock Investment Company, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Eagle Rock Investment Company, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Eagle Rock Investment Company, LLC with notifications on news.